Sanchez-Luna M, Burgos-Pol R, Oyagüez I, Figueras-Aloy J, Sánchez-Solís M, Martinón-Torres F, Carbonell-Estrany X
Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: update based on the clinical evidence in Spain
BMC Infect Dis. doi: 10.1186/s12879-017-2803-0
Crespo J, Esteban R, Torres C, Oyagüez I, Casado MA, Buti M